News

Updates on activities and accomplishments at AYOXXA

As a young and dynamic company determined to anticipate and respond to customer needs, we continue to achieve milestones, bring novel products to market, expand our partnerships, and explore use of our LUNARIS™ technology in new research areas. Follow these developments here.

Customer Testimonials

Webinars

Coronavirus Update

Conferences

Meet AYOXXA

AYOXXA @ 14th Annual Biomarkers Congress 2019 in Manchester

AYOXXA introduces its innovative LUNARIS™ technology to senior level attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions, all working in the biomarker space across multiple therapeutic areas worldwide.

Read more

Meet AYOXXA

AYOXXA @ 37th Annual J.P. Morgan Healthcare Conference

AYOXXA introduces its innovative LUNARIS™ platform to executives from internationally renowned pharmaceutical and biotech companies as well as to members of the investment community, meeting at the largest and most informative healthcare investment symposium in the industry from January 7 - 10, 2019 at the Westin St. Francis Hotel in San Francisco, California.

Read more

Meet AYOXXA

AYOXXA @ the "iSearch", Basic Research in Ophthalmology Meeting

iSearch is a forum for basic experimental research in ophthalmology, where new findings about signaling pathways and pathomechanisms involving immune cells of the retina are presented.

Read more

Meet AYOXXA

AYOXXA @ the 6th Annual Meeting of the International Cytokine & Interferon Society in Boston

AYOXXA will be at the epicenter of cytokine and interferon research to exhibit the LUNARIS™ platform with its growing portfolio of multiplex cytokine detection kits, and to discuss its unique advantages for basic and translational applications.

Read more

Meet AYOXXA

AYOXXA @ 3rd Annual Biomarkers Congress, San Diego

AYOXXA introduces its innovative LUNARIS™ platform to executives from internationally renowned pharmaceutical and biotech companies as well as to leading scientists from academic and government institutions, meeting in one of the most vibrant life science clusters in Southern California.

Read more

Meet AYOXXA

AYOXXA @ ECI 2018 in Amsterdam

AYOXXA will present its proprietary LUNARIS™ platform technology and growing portfolio of bead-based immunoassay detection kits at the 5th European Congress of Immunology.

Read more

Press Reviews

Press Releases

Press Release

Collaboration between AYOXXA and the Singapore Eye Research Institute

Singapore 2 March 2015 - AYOXXA, an international biotech company with headquarters in Cologne, has signed an agreement with the Singapore Eye Research Institute (SERI), one of the leading international eye research institutes. AYOXXA and SERI will work together on validating the company’s multiplexing technology platform for protein biomarker detection, as part of an expanded collaboration for developing ophthalmic diagnostic tools.

Read more

Press Release

AYOXXA BIOSYSTEMS appoints Dr. Gerald Möller as Chairman of the board

Cologne 14 September 2014 - AYOXXA Biosystems GmbH, an international biotechnology company, announced that Dr. Gerald Möller has joined the company's supervisory board as an independent board director and chairman of the board. With 40 years of experience in Pharma, Diagnostics and Biotech, Dr.

Read more

Press Release

AYOXXA Biosystems wins new investors to close a € 9,0m Series B round

Cologne 7. October 2014 - AYOXXA Biosystems GmbH, an international biotechnology company, completed a € 9,0m Series B financing round by the end of June 2014. All of the company’s existing investors (High-Tech Gründerfonds, KfW, NRW.BANK, Wellington Partners Venture Capital and private investors) took part, along with new investors b-to-v Partners AG, Creathor Venture and HR Ventures.

Read more

Press Release

AYOXXA BIOSYSTEMS Extends Series B

Cologne 2 December 2014 - AYOXXA Biosystems GmbH, an international biotechnology company, announces the closing of a third round of Series B financing, bringing the total amount raised to 11.3 Mio. EUR in 2014. An additional 2.3 Mio. EUR were now invested by BioMedPartners AG, Basel and Grazia Equity GmbH, based in Stuttgart, Germany.

Read more

Press Release

AYOXXA Biosystems schließt Serie A Finanzierungsrunde

Köln 20. September 2012 - AYOXXA Biosystems, ein internationales Biotechnologie-Unternehmen, hat heute den Abschluss einer Finanzierungsrunde in Höhe von 2,6 Millionen Euro mitgeteilt. Die Finanzierungsrunde wurde von Wellington Partners Venture Capital als Leadinvestor angeführt; weitere Investoren sind die NRW.BANK, der HTGF High-Tech-Gründerfonds sowie die Privatinvestoren Rainer Christine und Dr.

Read more

Still have any questions? Ask us!

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.